LONDON, March 19, 2024 /PRNewswire/ -- PharmaVentures is pleased to announce that it acted as the exclusive advisor to Phasefocus Holdings Limited on its sale to Bruker (NASDAQGS:BRKR). Phasefocus is a privately held company that has leading expertise in imaging, image processing algorithms and imaging platform. Phasefocus has deployed their expertise to develop a novel optical microscope, called Livecyte, for label-free cell imaging. Phasefocus' microscopy capabilities will enhance Bruker's existing portfo ...

It has been about a month since the last earnings report for Bruker (BRKR) . Shares have added about 15.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Bruker due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Bruker Q4 Earnings Top Estimates, Margins FallBruker Cor ...

Bruker Corporation (BRKR) appears in good shape, with its shares rising 20.7% since the fourth-quarter earnings release. The company continues to benefit from its innovative, high-performance product lines. The AI-driven semiconductor and advanced packaging metrology tools in the NANO group are performing well.The Zacks Rank #2 (Buy) stock has increased 20.7% since the last earnings release compared with the industry’s rise of 15%. The Medical sector has gained 3.6% in the said time frame. The company has a ...

Bruker Corporation (BRKR) recently announced its progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows at the 20th US Human Proteome Organization Congress 2024. The advances include improved machine-learning de novo sequencing (Novor V2.0), a novel high-performance monitoring digital-twin software (TwinScape), the new glyco-PASEF method for high-sensitivity glycopeptide analysis and access to Spectronaut 18 for users of Bruker ProteoScape — a GPU-powered software for r ...

BASEL, Switzerland--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions. This acquisition, first announced in January 2024, marks another significant milestone in Bruker’s expansion in vendor-agnostic scientific software, R&D and QC digitalization, and laboratory automation – altogether an important initiative within Bruker’s strategic P ...

Bruker Corporation (BRKR) recently entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of the pre-eminent private equity firm PAI Partners, to acquire ELITechGroup. However, the €870 million cash transaction excludes the carved-out ELITech clinical chemistry business.The transaction is expected to close in the second quarter of 2024, subject to regulatory approvals, the carve-out of the clinical chemistry business and other customary closing conditions. Upon closi ...

BRUKER CORPORATION ANNUAL REPORT ON FORM 10-K TABLE OF CONTENTS Part III Item 10 Directors, Executive Officers and Corporate Governance 111 Item 11 Executive Compensation 111 Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters 111 Item 13 Certain Relationships and Related Transactions, and Director Independence 111 Item 14 Principal Accountant Fees and Services 111 ITEM 1 BUSINESS BSI BioSpin Segment The BSI BioSpin Segment also offers a range of services, ...

Bruker (BRKR) continues to grow driven by its fundamental commitment to innovate high-value solutions and the ongoing portfolio transformation. However, Bruker’s operations face the downside of excessive currency exposure. The stock carries a Zacks Rank #3 (Hold) currently.Bruker’s CALID Group has been making decent progress lately, primarily because of the strong demand for differentiated instruments. The group is benefiting from sustained growth in the mass spectrometry business, including the FT-IR, Near ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences: Citi 2024 Unplugged Medtech and Life Sciences Access Day in New York City Thursday, February 29, 2024, at 8:45 a.m. Eastern Time TD Cowen 44th Annual Health Care Conference in Boston, MA Monday, March 4, 2024, at 9:50 a.m. Eastern Time Live audiovisual webcasts of the presentations will be avail ...

The Zacks Instruments - Scientific industry is benefiting from increasing healthcare spending, driven by an aging demography, and continued innovation in the pharma and life sciences end-markets. Higher demand for generic drugs and biosimilars is driving growth for scientific tool and apparatus providers. Industry participants like Mettler-Toledo International (MTD) and Bruker (BRKR) are gaining from the growing testing needs of newer biological drugs. Increased scrutiny of per and polyfluoroalkyl substance ...